Financials data is unavailable for this security.
View more
Year on year Medicofarma Biotech SA 's revenues fell -82.34% from 4.25m to 750.81k. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a loss of 1.59m to a larger loss of 3.44m.
Gross margin | 81.92% |
---|---|
Net profit margin | -199.65% |
Operating margin | -203.88% |
Return on assets | -17.87% |
---|---|
Return on equity | -27.15% |
Return on investment | -23.82% |
More ▼
Cash flow in PLNView more
In 2023, cash reserves at Medicofarma Biotech SA fell by 502.33k. Cash Flow from Financing totalled 596.70k or 79.47% of revenues. In addition the company generated 7.26k in cash from operations while cash used for investing totalled 1.11m.
Cash flow per share | -0.015 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.128 |
---|---|
Tangible book value per share | 0.1262 |
More ▼
Balance sheet in PLNView more
Current ratio | 0.8404 |
---|---|
Quick ratio | 0.8394 |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼